Atlas Trials

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT07068906 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07068906
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
B-Cell Non-Hodgkin Lymphoma
Start date
2025-07-15
Primary completion
2026-06-30
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.